Optimizing Treatment Management Strategies in AL Amyloidosis

Faculty share insights into the treatment strategies using CD-38-directed monoclonal antibodies in patients with AL amyloidosis.

Related Keywords

, Transforming Outcomes , Precision Medicine , Targeted Therapies , Treatment Management Strategies , Light Chain Amyloidosis , Al Amyloidosis , Andromeda , Daratumumab , Vital , Pronto , Affirm Al , Nexicart 1 , Amyloid Deposits , Cd 38 Directed Monoclonal Antibodies , Cardiac Involvement , Mayo Cardiac Staging , Stem Cell Transplant , Remission , Duration Of Therapy , Diagnosis , Unmet Needs , Managing Al Amyloidosis , Treating Al Amyloidosis , Nxc 201 , Cart Therapy , Amyloidosis Diagnosis , Prognosis , Mortality ,